Physician

Duane P. Moores, M.D.

According to 2025 Medicare claims, Duane Moores, M.D. (NPI: 1598755191) practices hematology/oncology in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is COOPERATIVE HEALTHCARE SERVICES INC (NPI: 1417979402; TIN: 010594994) and primary practice location at 31520-4270.

Moores' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 4,346 HCPCS/CPT codes, and received $136,334 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,042 prescription claims across 470 beneficiaries totaling $5,378,161 in drug costs, led by Xtandi (Enzalutamide). 2022 DME data shows 80 claims. Open Payments data shows 5 records totaling $240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,966,138 to $5,378,161. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,155 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	701	6,216	$171,834
2016	700	5,902	$161,939
2017	705	5,747	$150,582
2018	717	5,668	$158,760
2019	721	5,873	$162,209
2020	644	5,516	$148,521
2021	605	4,881	$148,705
2022	606	4,181	$135,253
2023	582	4,293	$135,130
2024	578	4,346	$136,334

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	338	2,754	$1,966,138
2016	319	2,448	$1,975,181
2017	319	2,461	$2,416,380
2018	329	2,434	$2,978,288
2019	350	2,814	$2,777,439
2020	368	2,864	$2,830,702
2021	380	3,168	$4,087,045
2022	384	2,984	$6,027,209
2023	384	3,404	$4,880,303
2024	470	4,042	$5,378,161

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	107	$32,328
2016	N/R	65	$21,575
2017	30	33	$7,303
2018	17	29	$7,123
2019	14	106	$35,843
2020	11	100	$7,707
2021	N/R	83	$3,491
2022	11	80	$9,551
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	126	180	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	445	747	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	304	346	$12
36415	Insertion of needle into vein for collection of blood sample	373	1,274	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	374	1,416	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	58	1,990	$919,233
Pomalyst	Pomalidomide	36	1,008	$868,619
Lenalidomide	Lenalidomide	50	1,337	$668,282
Jakafi	Ruxolitinib Phosphate	32	960	$455,440
Imbruvica	Ibrutinib	29	850	$416,056

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$240	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Duane P. Moores, M.D.?

Tedicare shows public-source Medicare data for Duane P. Moores, M.D. (NPI 1598755191), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Duane P. Moores, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Duane P. Moores, M.D.?

Duane P. Moores, M.D. is linked to COOPERATIVE HEALTHCARE SERVICES INC (billing NPI 1417979402) in the available physician profile data.

Does Duane P. Moores, M.D. have Open Payments data?

Duane P. Moores, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.